Short Bowel Syndrome clinical trials at University of California Health

1 research study open to eligible people

Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF
open to eligible people ages 18 years and up
The primary objective of the trial is the confirmation of the efficacy of apraglutide to evaluate the efficacy of weekly subcutaneous apraglutide in reducing parenteral support dependency.
at UCLA

Last updated: June 2022